Oral vinorelbine in the treatment of non-small cell lung cancer

Abstract

Vinorelbine is one of the standard drugs for the treatment of nonsmall cell lung cancer and is widely used in adjuvant therapy, chemoradiation programs, and in the treatment of common forms of the disease. The developed oral formulation of the drug provides comparable efficacy with much more convenient use. Vinorelbine capsules can be used both in combination with platinum derivatives, and in monotherapy with the possibility of using standard weekly and more frequent metronome dosing regimens. The efficacy and safety of oral vinorelbine has been proven, including for the elderly and debilitated population.